LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual... ...
http://in.reuters.com/article/2013/05/22/us-glaxosmithkline-usa-antibiotics-idINBRE94L0FG20130522?feedType=RSS&feedName=healthBy Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug... ...
http://reuters.in.feedsportal.com/c/35218/f/654194/s/2c3f23cc/l/0Lin0Breuters0N0Carticle0C20A130C0A50C220Ccancer0Eimmunotherapy0EidINDEE94L0A6L20A130A5220DfeedType0FRSS0GfeedName0FtopNews/story01.htmPosted by Equitymaster Indian share markets managed to remain just above the dotted line in the post-noon trading session. Majority of the sectoral... ...
http://feeds.equitymaster.com/~r/TodaysMarket/~3/yuG4Qyvxibg/tm.aspElan Corporation (ELN) recently provided an update on its strategic plans for the future. The company plans several acquisitions and has other... ...
http://in.quote.com/news/zacksCache.aspx?id=707997